Clinical Trial: Effectiveness and Tolerability of a Treat-to-Target Versus Fixed-Dose Statin Strategy in Patients With Atherosclerotic Cardiovascular Disease: A Randomized Controlled Trial

U.S., Nov. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07909915) titled 'Effectiveness and Tolerability of a Treat-to-Target Versus Fixed-Dose Statin Strategy in Patients With Atherosclerotic Cardiovascular Disease: A Randomized Controlled Trial' on Oct. 26.

Brief Summary: To compare the efficacy of fixed-dose versus treat-to-target statin regimens in achieving the predefined LDL-C target at 12 weeks in patients with established ASCVD.

To compare the frequency of adverse effects of statin therapy between patients receiving a fixed-dose regimen and those managed with a treat-to-target approach.

Study Start Date: Nov., 2026

Study Type: INTERVENTIONAL

Condition: Dyslipidemia, Hypercholesterolemia, Hyper...